Analysen von Richard Vosser
| 27.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 19.06.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 09.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.05.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.05.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.05.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 08.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 03.05.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 02.05.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 02.05.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.04.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 20.04.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 17.04.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 04.04.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.03.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.03.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 09.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.03.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 28.02.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 09.02.23 | Roche Underweight | JP Morgan Chase & Co. | |